Literature DB >> 31928746

Parkinson's disease: From bench to bedside.

A Draoui1, O El Hiba2, A Aimrane1, A El Khiat1, H Gamrani3.   

Abstract

Parkinson's disease is a very complex public health problem with different etiologies and a wide range of clinical features including motor and non-motor symptoms. The aim of the current report is to review the latest advances in the understanding of PD etiologies, diagnosis, epidemiology and an overview of the earlier and latest advances in the management of PD, from L-DOPA to adult astroglia reprogramming into dopaminergic neurons in vivo.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Epidemiology; Etiology; Neuroinflammation; Parkinson's disease; Pathophysiology; Risk factors; Symptomatology; Treatments

Mesh：

Substances：

Year:  2020        PMID： 31928746     DOI： 10.1016/j.neurol.2019.11.002

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN： 0035-3787            Impact factor:   2.607


  13 in total

Review 1.  PARP overactivation in neurological disorders.

Authors:  Vijay Kumar Arruri; Chayanika Gundu; Islauddin Khan; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Mol Biol Rep       Date:  2021-03-25       Impact factor: 2.316

2.  Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors.

Authors:  Dorota Łażewska; Agnieszka Olejarz-Maciej; David Reiner; Maria Kaleta; Gniewomir Latacz; Małgorzata Zygmunt; Agata Doroz-Płonka; Tadeusz Karcz; Annika Frank; Holger Stark; Katarzyna Kieć-Kononowicz
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

3.  Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson's Disease: An Up-and-Down Sequential Allocation Trial.

Authors:  Chengwei Yang; Fang Kang; Wenjun Meng; Meirong Dong; Xiang Huang; Sheng Wang; Zhiyi Zuo; Juan Li
Journal:  Clin Interv Aging       Date:  2021-01-15       Impact factor: 4.458

Review 4.  Impulse Control Disorders in Parkinson's Disease: From Bench to Bedside.

Authors:  Andrea Augustine; Catharine A Winstanley; Vaishnav Krishnan
Journal:  Front Neurosci       Date:  2021-03-12       Impact factor: 4.677

Review 5.  Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease.

Authors:  Daniel Aghaie Madsen; Sissel Ida Schmidt; Morten Blaabjerg; Morten Meyer
Journal:  Cells       Date:  2021-01-31       Impact factor: 6.600

6.  Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys.

Authors:  Marc Morissette; Mélanie Bourque; Marie-Ève Tremblay; Thérèse Di Paolo
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

7.  On the Effects of Transcranial Direct Current Stimulation on Cerebral Glucose Uptake During Walking: A Report of Three Patients With Multiple Sclerosis.

Authors:  Thorsten Rudroff; Alexandra C Fietsam; Justin R Deters; Craig D Workman; Laura L Boles Ponto
Journal:  Front Hum Neurosci       Date:  2022-01-25       Impact factor: 3.169

8.  Beneficial effect of transient desflurane inhalation on relieving inflammation and reducing signaling induced by MPTP in mice.

Authors:  Zhiyang Yu; Guowei Qin; Zhenzhong Ge; Weiyan Li
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

Review 9.  Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.

Authors:  Priscila Baltazar Gonçalves; Ana Carolina Rennó Sodero; Yraima Cordeiro
Journal:  Biomolecules       Date:  2021-05-20

Review 10.  Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach.

Authors:  Matteo Bordoni; Eveljn Scarian; Federica Rey; Stella Gagliardi; Stephana Carelli; Orietta Pansarasa; Cristina Cereda
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.